Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis.

Area of Science:

• Hematology
• Immunology
• Rheumatology

Background:

• Large granular lymphocyte (LGL) leukemia is a rare hematologic malignancy.
• Rheumatoid arthritis (RA) is a chronic autoimmune disease.
• A known association exists between LGL leukemia and RA, sharing common clinical and immunological features.

Purpose of the Study:

• To review and compare the features of LGL leukemia and RA.
• To explore potential mechanisms linking the pathogenesis of LGL leukemia and RA.
• To evaluate the hypothesis of LGL leukemia as a driver of RA.

Main Methods:

• Comparative analysis of disease features.
• Review of proposed mechanistic links between LGL leukemia and RA.
• Examination of evidence for cytotoxic T-cell (CTL) involvement in RA pathogenesis.

Main Results:

• Both LGL leukemia and RA exhibit cytotoxic T-cell (CTL) expansions, HLA-DR4 enrichment, and RA-associated autoantibodies.
• Three potential mechanisms link LGL leukemia and RA: LGL leukemia as a result of RA, a consequence of RA treatment, or a driver of RA.
• Evidence supports CTLs in RA pathogenesis through citrullination and granzyme B cleavage, modifying self-antigens in neutrophils.

Conclusions:

• LGL leukemia may act as a driver of RA pathogenesis.
• CTLs play a significant role in RA, potentially by modifying self-antigens.
• Further research is needed to elucidate causal pathways and identify target antigens for improved therapies for both conditions.